Promoting effects of antiandrogenic agents on rat ventral prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl (DMAB)

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 2, 2000, Pages 115-119

  Akaza, H ^a   Tsukamoto, S ^a   Morita, T ^a   Yamauchi, A ^a   Onozawa, M ^a   Shimazui, T ^a   Ideyama, Y ^b   Shirai, T ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

5 reductase inhibitor; Anti androgen; Cancer prevention; Prostate cancer; Rat experimental model

Indexed keywords

2 (1H IMIDAZOL 4 YLMETHYL) 9H CARBAZOLE; 2',3 DIMETHYL 4 BIPHENYLAMINE; ANTIANDROGEN; BICALUTAMIDE; EPRISTERIDE; LYASE INHIBITOR; STEROID 5ALPHA REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MALE GENITAL TRACT CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; STEROID BLOOD LEVEL;

EID: 0033837252     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500409     Document Type: Article

References (15)

1. 5-Alpha-reductase inhibition and prostate cancer prevention
2. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. The finasteride study group
3. Antiandrogens and 5-alpha reductase inhibition of the proliferation rate in PC-3 and DU-145 human prostatic cancer cell line
4. The development of casodex (bicalutamide): Preclinical studies
5. Antiandrogens: Preclinical and clinical studies
6. Chemoprevention of rat prostate carcinogenesis by use of finasteride or casodex
7. A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats
8. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2*-dimethyl-4-aminobiphenyl and testosterone propionate
9. Site-specific effects of testosterone propionate on the prostate of rat pretreated with 3,2'-dimethyl-4-aminobiphenyl: Dose-dependent induction of invasive carcinomas
10. Duration dependent induction of invasive prostate carcinomas with pharmacological dose of testosterone propionate in rats pretreated with 3,2'-dimethyl-4-aminobiphenyl and development of androgen-independent carcinomas after castration
11. Variation in tumor yield in the prostate and other target organs of rat in response to varied dosage and duration of administration of 3,2*-dimethyl-4-aminobiphenyl
12. Induction of prostate cardnoma in situ at high incidence in F344 rats by a combination of 3,2'-dimethyl-4-aminobiphenyl and ethinyl estradiol
13. Novel nonsteroidal inhibitor of cytochrome P450-17α (17α-hydroxylase/C17-20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats
14. Geographic pathology of latent prostatic carcinoma
15. Prehn. On the prevention and therapy of prostate cancer by androgen administration